Janis Marie Taube
机构：Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center · ORCID：0000-0002-8273-4395
发表论文 574 篇 · 总被引 76932 次 · h-index 89
代表论文
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer (2025 · New England Journal of Medicine · 被引 236)
- Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols (2025 · Journal for ImmunoTherapy of Cancer · 被引 49)
- Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 1/2 trial (2025 · Nature Medicine · 被引 44)
- Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (2025 · Journal of Thoracic Oncology · 被引 26)
- Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing (2025 · Journal for ImmunoTherapy of Cancer · 被引 26)
- Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses (2025 · Nature Medicine · 被引 22)